Suppr超能文献

相似文献

1
Oxidation of lanthionines renders the lantibiotic nisin inactive.
Appl Environ Microbiol. 2009 Mar;75(5):1381-7. doi: 10.1128/AEM.01864-08. Epub 2008 Dec 29.
2
Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Microb Drug Resist. 2012 Jun;18(3):261-70. doi: 10.1089/mdr.2011.0242. Epub 2012 Mar 20.
4
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Appl Environ Microbiol. 2006 Apr;72(4):2809-14. doi: 10.1128/AEM.72.4.2809-2814.2006.
5
Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
ACS Chem Biol. 2011 Jul 15;6(7):744-52. doi: 10.1021/cb1004178. Epub 2011 May 5.
6
Elucidation of the antimicrobial mechanism of mutacin 1140.
Biochemistry. 2008 Mar 11;47(10):3308-14. doi: 10.1021/bi701262z. Epub 2008 Feb 12.
7
A lesson in efficient killing from two-component lantibiotics.
Mol Microbiol. 2006 Jul;61(2):271-3. doi: 10.1111/j.1365-2958.2006.05239.x. Epub 2006 Jun 12.
8
Contributions of the σ(W) , σ(M) and σ(X) regulons to the lantibiotic resistome of Bacillus subtilis.
Mol Microbiol. 2013 Nov;90(3):502-18. doi: 10.1111/mmi.12380. Epub 2013 Sep 16.
10
Assembly and stability of nisin-lipid II pores.
Biochemistry. 2004 Sep 14;43(36):11567-75. doi: 10.1021/bi049476b.

引用本文的文献

3
The modification of nisin with homocysteine thiolactone and its effect on antimicrobial activity.
Braz J Microbiol. 2024 Mar;55(1):191-199. doi: 10.1007/s42770-023-01207-8. Epub 2023 Dec 12.
4
Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review.
Pharmaceuticals (Basel). 2023 Jul 26;16(8):1058. doi: 10.3390/ph16081058.
6
Pectin-gellan films intended for active food packaging: release kinetics of nisin and physico-mechanical characterization.
J Food Sci Technol. 2021 Aug;58(8):2973-2981. doi: 10.1007/s13197-020-04800-z. Epub 2020 Sep 21.
7
Isolation, Characterization and Structure Elucidation of a Novel Lantibiotic From sp.
Front Microbiol. 2020 Nov 24;11:598789. doi: 10.3389/fmicb.2020.598789. eCollection 2020.
8
Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
Appl Environ Microbiol. 2018 Jul 17;84(15). doi: 10.1128/AEM.00830-18. Print 2018 Aug 1.
9
Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
Appl Environ Microbiol. 2018 Feb 14;84(5). doi: 10.1128/AEM.02528-17. Print 2018 Mar 1.
10
Antimicrobial peptides sourced from post-butter processing waste yak milk protein hydrolysates.
AMB Express. 2017 Dec 6;7(1):217. doi: 10.1186/s13568-017-0497-8.

本文引用的文献

1
Elucidation of the antimicrobial mechanism of mutacin 1140.
Biochemistry. 2008 Mar 11;47(10):3308-14. doi: 10.1021/bi701262z. Epub 2008 Feb 12.
2
Complex reactions catalyzed by cytochrome P450 enzymes.
Biochim Biophys Acta. 2007 Mar;1770(3):314-29. doi: 10.1016/j.bbagen.2006.07.003. Epub 2006 Jul 13.
4
C terminus of NisI provides specificity to nisin.
Microbiology (Reading). 2006 Dec;152(Pt 12):3543-3549. doi: 10.1099/mic.0.29083-0.
6
An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Science. 2006 Sep 15;313(5793):1636-7. doi: 10.1126/science.1129818.
8
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Antimicrob Agents Chemother. 2006 Apr;50(4):1449-57. doi: 10.1128/AAC.50.4.1449-1457.2006.
9
Lipid II as a target for antibiotics.
Nat Rev Drug Discov. 2006 Apr;5(4):321-32. doi: 10.1038/nrd2004.
10
Cytochrome P450: nature's most versatile biological catalyst.
Annu Rev Pharmacol Toxicol. 2005;45:1-25. doi: 10.1146/annurev.pharmtox.45.120403.100030.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验